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Abstract 
The prevalence of cancer in small and diminutive polyps is relevant to “resect and discard” and 
CT colonography reporting recommendations. 
We evaluated a prospectively collected colonoscopy polyp database   to identify polyps < 10 mm 
and those with cancer or advanced histology (high-grade dysplasia or villous elements) 
Of 32,790 colonoscopies, 15,558 colonoscopies detected 42,630 polyps < 10 mm in size.  A total 
of 4,790 lesions were excluded as they were not conventional adenomas or serrated class lesions. 
There were 23,524 conventional adenomas < 10 mm of which 22,952 were tubular adenomas. 
There were 14,316 serrated class lesions of which 13,589 were hyperplastic polyps and the 
remainder were sessile serrated polyps. Of all conventional adenomas, 96 had high-grade 
dysplasia including 0.3% of adenomas ≤ 5 mm in size and 0.8% of adenomas 6-9 mm in size. Of 
all conventional adenomas, 2.1% of those ≤ 5 mm in size and 5.6% of those 6-9 mm in size were 
advanced. Among 36,107 polyps ≤ 5 mm in size and 6,523 polyps 6-9 mm in size, there were no 
cancers. 
These results support the safety of resect and discard as well as current CT colonography 
reporting recommendations for small and diminutive polyps. 
Key words: Diminutive polyps, small polyps, colorectal cancer, adenomas, serrated lesions, 
resect and discard, CT colonography. 
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INTRODUCTION 
The risk of cancer in small and diminutive colorectal polyps remains an important factor 
in several polyp management paradigms.  For example, the risk of cancer in the resect and 
discard paradigm is important, since resect and discard 1 could potentially result in a small polyp 
with cancer being discarded after resection, and the cancer thus going unrecognized.  Such an 
event could result in an adverse outcome for a patient if a cancer recurrence developed.  
Similarly, the prevalence of cancer in diminutive and small polyps is important in computed 
tomography (CT) colonography management paradigms, where diminutive polyps are not 
reported 2, and small polyps may not be recommended for immediate resection 2. 
Early studies of cancer prevalence in small and diminutive polyps found a substantial 
cancer risk, which exceeded 0.4% in polyps 6 to 9 mm in size in some studies 3-7.  However, 
more recent colonoscopic studies found a much lower prevalence 8-15.  These differences may 
reflect in part the improved potential for polyp identification resulting from progressive 
improvements in colonoscope imaging.  Thus, increasing emphasis on maximizing adenoma 
detection could result in a broader range of lesions removed, including many with a more subtle 
and flat morphology than was detectable in early studies.  Contrary to some suggestions, flat 
morphology without depression is not associated with an increased risk of advanced pathology 
and may be associated with a lower risk of advanced pathology 16-18. 
The prevalence of cancer in diminutive polyps is of great interest to some patients who 
are considering whether to participate in the resect and discard paradigm of small polyp 
management 19.  Determining this risk of cancer within narrow confidence limits is an important 
goal.  We now report the largest single experience on the prevalence of cancer in small and 
diminutive polyps.  This study exceeds the size of all prior studies on this topic combined. 
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MATERIALS AND METHODS 
We prospectively maintained a database of colonoscopies and polyp findings 
continuously since the year 2000 in our endoscopy units.  The current report describes 
colonoscopies performed beginning in February 2004 and extending to September 2015. 
Permission to review the database was granted by the Institutional Review Board at Indiana 
University School of Medicine on September 29, 2015. 
The database includes the endoscopist performing the examination, polyp size (as 
measured by endoscopist estimate), polyp location in the colon (by endoscopist estimate), and 
pathology as reported by our university pathologists.  
Conventional adenomas were those interpreted by the pathologists as tubular, 
tubulovillous, or villous. Serrated class lesions were those interpreted as hyperplastic polyp, 
sessile serrated polyp, sessile serrated adenoma, or serrated adenoma, or traditional serrated 
adenoma.  
Statistical analysis was descriptive. 
 
RESULTS 
A total of 32,790 colonoscopies were performed during the study period by 53 different 
endoscopists. There were 15,558 procedures that identified 42,630 polyps < 10 mm in size for 
which the polyp was resected and a pathology report was created.  The mean age was 60.1 years 
(59.7 years in females, 60.2 years in males).  There were 1,890 procedures in persons < 50 years 
of age, and 649 in persons 80 years and older.  
Polyps (n=4,790) that were not considered conventional adenomas or serrated class 
lesions were excluded from further analysis.  These included normal tissue/mucosa (n = 3,833), 
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inflammatory polyps (n = 574), lymphoid follicles (n = 293), granulation tissue (n = 60), 
hamartoma (n = 14), carcinoid tumor (n=13), metastatic malignant melanoma (n = 2), and 
granular cell tumor (n = 1).  
There were 23,524 conventional adenomas < 10 mm in size, of which 22,952 (97.6%) 
were tubular adenomas.  There were 14,316 serrated class lesions < 10 mm in size, of which 
13,589 (95%) were interpreted as hyperplastic polyps, and the remainder were sessile serrated 
polyps or "serrated adenoma" (Table 1).  Polyps < 10 mm in size comprised 88.4% of all 
resected polyps. 
Among all conventional adenomas, 96 had high-grade dysplasia, including 0.3% of 
adenomas ≤ 5 mm in size and 0.8% of conventional adenomas 6 to 9 mm in size. The fraction of 
conventional adenomas ≤ 5 mm in size that were advanced (had either villous elements or high-
grade dysplasia) was 2.1%. The fraction of 6-9 mm conventional adenomas that were advanced 
was 5.6%. 
There were no cancers among 36,107 polyps ≤ 5 mm in size and 6,523 polyps 6 to 9 mm 
in size. 
 
DISCUSSION 
In this report, we describe the largest reported experience with identification of cancer in 
colorectal polyps < 10 mm in size.  This study exceeds the size of all previous studies on this 
topic combined (Table 2).  We found no cancers in nearly 36,000 polyps ≤ 5 mm in size, and 
none in 6,523 polyps 6 to 9 mm in size.   Our results indicate that the risk of cancer in diminutive 
and small polyps is very low. These results substantially improve the projected safety of resect 
and discard paradigm 1 and of current reporting recommendations for CT colonography 2. 
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Our results are consistent with much of the previously published literature 3-15,20-27, 
particularly reports from the last 10 years (Table 2).  As noted earlier, the trends toward 
decreasing prevalence rates of cancer in small and diminutive polyps may reflect the improved 
imaging capabilities of colonoscopes, and increasing emphasis on identification of flat lesions 
which do not increase the risk of cancer compared to polypoid lesions 16-18. 
The overall distribution of polyp sizes in this study suggests that the tendency of 
endoscopists in our unit is to underestimate polyp size, particularly since the percentage of all 
polyps < 1 cm in size was comparable to other studies 3-15,21-27, despite our center receiving many 
referrals for large and complex polypectomies 28.  Further the fraction of polyps ≤ 5 mm and 6-9 
mm in size was comparable to or higher than prior studies 3-17,22-29. Any underestimation of polyp 
size would tend to cause the apparent prevalence of cancer in polyps of different size ranges to 
increase.  Despite this apparent tendency to underestimate polyp size, no cancers were identified 
in small and diminutive polyps.  
The prevalence of villous elements and high-grade dysplasia in small and diminutive 
polyps in the study was very low, and lower than noted in a number of other reports (Table 2).  
However, we have demonstrated that interpretation of villous elements and dysplasia grade in 
small polyps is subject to extreme interobserver variation and poor agreement even among 
experts 29.  These features have caused the British Society of Gastroenterology to ignore villous 
elements and dysplasia grade in their post polypectomy surveillance guideline 30.  We previously 
reported that experts in gastrointestinal pathology do not use the same definitions of high-grade 
dysplasia 29.  Specifically, pathologists who utilize cytologic criteria for high-grade dysplasia 
report much higher prevalence rates of high-grade dysplasia compared to those who use only 
morphologic criteria 29.  At the direction of the gastrointestinal pathologists in our unit, our 
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pathologists utilize only morphologic criteria for high-grade dysplasia, which undoubtedly 
contributes to the low prevalence of high-grade dysplasia in our study.  Similarly, there is 
marked interobserver variation in the interpretation of sessile serrated polyp vs. hyperplastic 
polyp 31,32.  We had previously demonstrated that experts identify a higher percentage of sessile 
serrated polyps than are identified by our own pathologists 32.  However, experts also exhibit 
significant interobserver variation 31.  Therefore, our data on the prevalence of sessile serrated 
polyp reflect a conservative approach to interpretation of this lesion, as well as evolving 
awareness of sessile serrated polyp by pathologists during the study period.  Our focus in this 
paper is on the prevalence of cancer in small and diminutive polyps.  Interpretation of cancer by 
community pathologists in colorectal polyps appears to be consistent and reliable 33, as does the 
assignment of colorectal polyps to the conventional adenoma vs. serrated class 1,33.  Thus, the 
pathology reports with regards to the prevalence of cancer in diminutive and small polyps should 
be reliable.  
Strengths of our study include its large size, which far exceeds the size of any previous 
study on this topic, and is slightly larger than the size of all previous studies on this topic 
combined (Table 2).  There are few databases available that include pathology results on 
individual polyps < 10 mm in size.   
Limitations include the retrospective nature of the study, though the database was 
accumulated prospectively. Additionally, polyp size was estimated endoscopically, though as we 
noted above the distribution of polyp sizes does not suggest any tendency to overestimate lesion 
size. 
In summary, we did not identify any cancers in a large sample of diminutive and small 
colorectal polyps.  This result favors the feasibility of strategies such as resect and discard 1, and 
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favors the appropriateness of current CT colonography reporting recommendations for 
diminutive and small polyps 2. 
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Table 1. Prevalence of cancer in diminutive and small colorectal polyps 
 
Polyp 
Pathology 
Size 
Total number 
of polyps  
Tubular 
adenoma        
n (%) 
Tubulovillous 
adenoma                  
n (%) 
Villous 
adenoma        
n (%) 
High-grade 
Dysplasia      
n (%) 
Cancer 
n (%) 
Hyperplastic 
polyp n (%) 
Sessile 
serrated 
polyp n (%) 
≤ 5 mm 19,559 19,191 (98.1%) 357 (1.8%) 11 (0.1%) 66 (0.3%) 0 - - 
6-9 mm 3,965 3,761 (94.9%) 202 (5.1%) 2 (0.1%) 30 (0.8%) 0 - - 
≤ 5 mm 12,214 - - - - 0 11,772 (96.4%) 442 (3.6%) 
6-9 mm 2,102 - - - - 0 1,817 (86.4%) 285 (13.6%) 
Table 2: Previously published data on the prevalence of advanced adenomas and caner in small and diminutive polyps 
 
*: High grade dysplasia only 
Study 
Number of 
Diminutive 
Adenomas (Size 
Range) 
Number of 
Diminutive 
Adenomas with 
Advanced 
Histology (%) 
Number of 
Diminutive 
Carcinomas (%) 
Number of Small 
Adenomas (Size 
Range) 
Number of Small 
Adenomas with 
Advanced 
Histology (%) 
Number of Small 
Carcinomas (%) 
Shinya et al. 1979 3    1661 (5-9 mm) 249 (15%)** 8 (0.5%) 
National Polyp Study, 1990 20  1270 (<6 mm) 25 (2%)**  1230 (6-10 mm) 155 (12.6%)** - 
Weston et al. 1995 21 1964 (<= 5 mm) 5 (0.3%) 0    
Aldridge et al. 2001 22 194 (<= 5 mm) 71 (36.5%)** 0 163 (6-10 mm) 99 (60.7%)** 2 (0.01%) 
Gshwantler et al. 2002 4 3016 (<5 mm) 561 (18.6%)** 0 2789 (5-10 mm) 1080 (38.7%)** 26 (0.9%) 
Kapsoritakis et al. 2002 23 293 (<= 5 mm) 6 (2%)* 0    
Pickhardt et al. 2003 24 966 (<=5 mm) 1 (0.1%) 0 262 (6-9 mm)  0 
Church et al. 2004 25 4381 (<6 mm) 91 (2.1%) 2 (0.05%) 666 (6-10 mm) 65 (9.8%) 1 (0.15%) 
Odom et al. 2005 5 2851 (<= 5 mm)  1 (0.03%) 152 (6-10 mm)  1 (0.65%) 
Butterly et al. 2006 7 1305 (<6 mm) 34 (2.6%)** 1 (0.08%) 487 (6-9 mm) 38 (7.8%)** 2 (0.4%) 
Sprung et al. 2006 26    6694 (5-10 mm)  2 (0.03%) 
Yoo et al. 2007 6 3303 (<= 5 mm) 5 (0.15%) 1 (<0.01%) 1432 (6-9 mm) 31 (2.2%) 7 (0.49%) 
Kim et al. 2007 8 2006 (<=5 mm) 4 (0.2%) 0    
Lieberman et al. 2008 9 3744 (<=5 mm) 62 (1.7%)*** 1 (0.02%) 1198 (6-9 mm) 77 (6.4%)*** 2 (0.2%) 
Graser, 2009 10 418 (<= 5 mm) 7 (1.7%)** 0 56 (6-9 mm) 6 (10.7%)** 0 
Bretagne et al. 2010 11 535 (<=5 mm) 15 (2.8%)* 0 219 (6-9 mm) 34 (15.5%)* 0 
Chaput et al. 2011 12 342 (<=5 mm) 16 (4.7%) 0 72 (6-9 mm) 25 (35.2%) 0 
Tsai et al. 2011 13 1025 (<= 5 mm) 105 (10%) 0 247 (6-9 mm) 67 (27%) 0 
Denis et al. 2011 14 180 (<= 5 mm) 22 (12.2%)  29 (6-9 mm) 13 (44%) 0 
Gupta et al. 2012 15 1620 (<= 5 mm) 9 (0.6%)** 0 455 (6-9 mm) 7 (1.5%)** 0 
Kaltenbach et al. 2014 27 975 (<= 5 mm) 1 (0.10%) 0       
Pooled data 30,388 1,040 (3.42%) 6 (0.02%) 17,812 1,946 (10.9%) 51 (0.28%) 
**: High grade dysplasia, villous and tubulovillous category 
***: High grade dysplasia, villous and tubulovillous, serrated category 
 
